For the quarter ending 2025-12-31, REPL had $20,652K increase in cash & cash equivalents over the period. -$66,090K in free cash flow.
| Cash Flow | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|
| Net loss | -70,930 | -83,100 | -86,693 |
| Stock-based compensation expense | 7,047 | 8,338 | 8,762 |
| Depreciation and amortization | 848 | 842 | 873 |
| Operating lease, right-of-use-asset amortization | 194 | 191 | 185 |
| Finance lease, right-of-use-asset amortization | 607 | 607 | 607 |
| Net amortization of premiums and discounts on short-term investments | 134 | 759 | 1,339 |
| Noncash interest expense | 425 | 414 | 415 |
| Unrealized foreign currency transaction (gains) losses | 581 | 875 | -591 |
| Research and development incentives receivable | 349 | 367 | -1,631 |
| Prepaid expenses and other current assets | -36 | 140 | -234 |
| Other non-current assets | 0 | - | - |
| Accounts payable | -730 | -8,930 | 3,765 |
| Accrued expenses and other current liabilities | -1,913 | 2,770 | -5,536 |
| Operating lease liabilities | -207 | -203 | -195 |
| Other non-current liabilities | -268 | 0 | -316 |
| Net cash used in operating activities | -65,955 | -81,212 | -77,016 |
| Purchases of property, plant and equipment and software capitalization | 135 | 1,343 | 2,740 |
| Purchase of short-term investments | 26,511 | 9,849 | 37,581 |
| Proceeds from sales and maturities of short-term investments | 101,766 | 95,361 | 105,369 |
| Net cash provided by (used in) investing activities | 75,120 | 84,169 | 65,048 |
| Proceeds from issuance of common stock, net of fees and offering costs | - | 0 | 0 |
| Proceeds from issuance of common stock-Common Stock | 0 | - | - |
| Proceeds from issuance of prefunded warrants to purchase common stock, net of underwriting fees and offering costs | 0 | 0 | 0 |
| Proceeds from issuance of common stock-ATMOffering | 10,364 | - | - |
| Principal payment of finance lease obligation | 195 | 177 | 166 |
| Proceeds from exercise of stock options and pre-funded warrants | 282 | 501 | 8 |
| Net cash provided by financing activities | 10,451 | 324 | -158 |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | 1,036 | 1,642 | -1,616 |
| Net increase in cash, cash equivalents and restricted cash | 20,652 | 4,923 | -13,742 |
| Cash and cash equivalents at beginning of period | 104,003 | 112,822 | - |
| Cash and cash equivalents at end of period | 124,655 | 104,003 | - |
Replimune Group, Inc. (REPL)
Replimune Group, Inc. (REPL)